Abstracts tagged "spondylarthritis and uveitis"

Abstract Number: 1592 • 2018 ACR/ARHP Annual Meeting
Frequency and Pattern of the Uveitis in Spondyloarthritis with Biological Therapy
Itziar Calvo Zorrilla¹, Edurne Guerrero Basterretxea¹, Oihane Ibarguengoitia¹, David Montero¹, Maria Luz Garcia Vivar¹, Esther Ruíz Lucea², Ignacio Torre Salaberri², Olaia Begoña Fernandez Berrizbeitia², Juan Maria Blanco Madrigal², Ana Rosa Inchaurbe Pellejero¹, Clara Eugenia Perez Velasquez², Natalia Rivera-García³, Maria Jesus Allande Lopez Linares³, Iñigo Gorostiza-Hormaetxe⁴ and Eva Galíndez Agirregoikoa², ¹Rheumatology, Rheumatology Department; Basurto University Hospital, Bilbao, Spain, ²Rheumatology Department; Basurto University Hospital, Bilbao, Spain, ³Rheumatology, University Hospital of Basurto, Bilbao, Spain, ⁴Research Department, Basurto University Hospital, Bilbao, Spain
Background/Purpose: Uveitis is the most frequent extra-articular manifestation (EAM) of spondyloarthritis (SpA). Its prevalence is approximately 30% and increases with the duration of the SpA. The…
Abstract Number: 1631 • 2018 ACR/ARHP Annual Meeting
Incidence of Uveitis in Patients with Spondyloarthritis: The Impact of Biologics Era.a Multicenter Study Using Data from International ASAS-Comospa Study
Hernán Maldonado Ficco¹, Rodolfo Perez-Alamino², Christian A. Waimann³, José A. Maldonado-Cocco⁴, Anna Moltó⁵, Maxime Dougados⁶, Robert B.M. Landewé⁷, Désirée van der Heijde⁸ and Filip van Den Bosch⁹, ¹Rheumatology Section, Hospital San Antonio de Padua, Río Cuarto- Córdoba, Argentina, ²Rheumatology Department, Hospital de Clínicas Pte. Dr. Nicolás Avellaneda, Tucumán, Argentina, ³Hospital Dr. Hector Cura, Olavarria, Argentina, ⁴Buenos Aires University, University of Buenos Aires School of Medicine. Argentina, Buenos Aires, Argentina, ⁵Rheumatology Department, Hôpital Cochin, AP-HP, Paris, France, ⁶Hopital Cochin, Paris, France, ⁷Amsterdam Rheumatology & Clinical Immunology Center and Zuyderland Medical Center, Amsterdam; Heerlen, Netherlands, ⁸Leiden University Medical Center, Leiden, Leiden, Netherlands, ⁹Department of Rheumatology, University of Ghent, Ghent, Belgium, Ghent, Belgium
Background/Purpose: Uveitis is a common extra-articular manifestation in Spondyloarthritis (SpA). The purpose of this study was to analyze incidence of uveitis in SpA patients during…
Abstract Number: 1639 • 2018 ACR/ARHP Annual Meeting
Uveitis As First Symptom in Patients with Spondyloarthritis. Data from the Spanish Registry Regisponser
Clementina López-Medina^1,2, María Lourdes Ladehesa-Pineda³, Pilar Font-Ugalde², M. Carmen Castro-Villegas³, Laura Pérez Sánchez⁴, Ignacio Gómez-García⁵, Alejandro Escudero-Contreras⁶ and Eduardo Collantes-Estévez², ¹Rheumatology Department, Cochin Hospital, Paris, France, ²Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, ³Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain, ⁴IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain, ⁵Rheumatology, Hospital Universitario Reina Sofia, CÓRDOBA, Spain, ⁶Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain
Background/Purpose: The objectives of this study were: a) to assess the prevalence of uveitis in patients with Spondyloarthritis (SpA) in the Spanish registry REGISPONSER; b)…
Abstract Number: 1646 • 2018 ACR/ARHP Annual Meeting
Prevalence of Spondyloarthritis in Patients with Anterior Uveitis
Kristyna Bubova^1,2, Monika Gregová^1,2, Katerina Zegzulkova^1,2, Karel Pavelka^1,2, Jarmila Heissigerova^3,4 and Ladislav Šenolt^2,5, ¹Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, ²Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, ³Department of Ophthalmology, First Faculty of Medicine, Charles University, Prague Czech Republic, Prague, Czech Republic, ⁴Department of Ophthalmology, General University Hospital in Prague, Prague, Czech Republic, Prague, Czech Republic, ⁵First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic
Background/Purpose: Anterior uveitis (AU) is a common extraarticular manifestation in spondyloarthritis (SpA). The disease can precede the typical axial and peripheral features. Additionally, some studies…
Abstract Number: 1647 • 2018 ACR/ARHP Annual Meeting
Uveitis, the Most Faithful Partner of Axial Spondyloarthritis
Dafne Capelusnik¹, Malena Cavalieri², Roger Rolon Campuzano³, Maria Celeste Orozco⁴, Natalia Zamora⁵, Emilce E Schneeberger⁶ and Gustavo Citera⁷, ¹Reumatology, Instituto de Rehabilitación Psicofísica, Argentina, CABA, Argentina, ²Reumatologia, Instituto de Rehabilitación Psicofísica, CABA, Argentina, ³Section of Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, Buenos Aires, Argentina, ⁴Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁵Reumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, Buenos Aires, Argentina, ⁶Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ⁷Rheumatology Section, Instituto de Rehabilitación Psicofísica, CABA, Argentina
Background/Purpose: Acute Anterior Uveitis (AAU) is the most frequent extra-articular manifestation in axial Spondyloarthritis (axSpA), with an overall prevalence of 32.7%. It is a manifestation…
Abstract Number: 1661 • 2018 ACR/ARHP Annual Meeting
Factors That May be Associated with Uveitis in Patients with Spondyloarthritis
Timucin Kasifoglu¹, Nazife Sule Yasar Bilge², Sedat Kiraz³, Ihsan Ertenli⁴, Orhan Kucuksahin⁵, Ediz Dalkiliç⁶, Cemal Bes⁷, Nilufer Alpay Kanitez⁸, Pamir Atagunduz⁹, Belkıs Nihan Coşkun¹⁰, Burcu Yagız¹¹, Suleyman Serdar Koca¹², Muhammed Cinar¹³, Aşkın Ateş¹⁴, Servet Akar¹⁵, Onay Gercik¹⁶, Duygu Ersozlu Bakirli¹⁷, Veli Yazisiz¹⁸, Gezmis Kimyon¹⁹, Muge Aydin Tufan²⁰, Hakan Emmungil²¹, Rıdvan Mercan²², Erdal Bodakci²³, Burak Oz²⁴, Zeynel Abidin Akar²⁵, Omer Karadag³, Bahar Kelesoglu²⁶, Sedat Yılmaz²⁷, Ufuk Ilgen²⁸, Yavuz Pehlivan²⁹, Ender Terzioglu³⁰, Levent Kilic⁴, Sukran Erten³¹, Koray Tascilar³² and Umut Kalyoncu³³, ¹Department of Internal Medicine, Division of Rheumatology, Eskisehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey, ²Rheumatology, Eskisehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey, ³Rheumatology, Hacettepe University, Faculty of Medicine, Ankara, Turkey, ⁴Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ⁵Rheumatology, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey, ⁶Department of Internal Medicine, Division of Rheumatology, Uludağ University Faculty of Medicine, Bursa, Turkey, ⁷Department of Rheumatology, Health Sciences University Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey, ⁸Rheumatology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, İstanbul, Turkey, ⁹Department of Internal Medicine, Division of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey, ¹⁰Rheumatology, Uludag University Faculty of Medicine, Bursa, Turkey, ¹¹Uludag University, Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey, ¹²Rheumatology, Firat University Faculty of Medicine, Elazığ, Turkey, ¹³GATA, Ankara, Turkey, ¹⁴Department of Internal Medicine, Division of Rheumatology, Ankara University School of Medicine, Ankara, Turkey, ¹⁵Department of Internal Medicine, Division of Rheumatology,, Izmir Katip Çelebi University Faculty of Medicine, Izmir, Turkey, ¹⁶Rheumatology, Izmir Katip Celebi University School of Medicine, Izmir, Turkey, ¹⁷PsART study group, Adana, Turkey, ¹⁸Rheumatology, Akdeniz University Faculty of Medicine, Antalya, Turkey, ¹⁹Rheumatology, Hatay Mustafa Kemal University Faculty of Medicine, Hatay, Turkey, ²⁰Rheumatology, Cukurova University School of Medicine, Adana, Turkey, ²¹Department of Internal Medicine, Division of Rheumatology, Trakya University Faculty of Medicine, Edirne, Turkey, ²²PsART study group, Tekirdag, Turkey, ²³Eskisehir Osmangazi University, Eskisehir, Turkey, ²⁴Fırat University, Elazıg, Turkey, ²⁵Frat University, Elazıg, Turkey, ²⁶Rheumatology, Ankara University, Ankara, Turkey, ²⁷Rheumatology Division, Gülhane Training and Research Hospital, Ankara, Turkey, ²⁸Rheumatology, Trakya University, Edirne, Turkey, ²⁹Bursa Uludag University, Bursa, Turkey, ³⁰Rheumatology, Akdeniz University, Antalya, Turkey, ³¹PsART study group, Ankara, Turkey, ³²Numune Research and Teaching Hospital, Ankara, Turkey, ³³Department of Internal Medicine, Divison of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey
Factors That May Be Associated With Uveitis In Patients With SpondyloarthritisBackground/Purpose: It is known that uveitis is present in the extra-articular findings of spondyloarthritis (SPA)…
Abstract Number: 271 • 2017 ACR/ARHP Annual Meeting
The Trend of Incidence Rate, Frequency and HLA Phenotype of Reactive Arthritis and Uveitis in Japanese Patients with Bladder Cancer Following Intravesical BCG Therapy: A 20-Year, Two-Center Retrospective Study
Yoshinori Taniguchi¹, Satoshi Inotani², Hirofumi Nishikawa², Kosuke Inoue³, Taro Horino², Takashi Karashima⁴, Yasuhiko Yoshinaga⁵ and Yoshio Terada³, ¹Endocrinology, Metabolism,Nephrology and Rheumatology, Kochi University, Kochi, Japan, ²Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi Medical School, Nankoku, Japan, ³Kochi University, Nankoku, Japan, ⁴Urology, Kochi University, Nankoku, Japan, ⁵Kurashiki Medical Center, Kurashiki, Japan
Background/Purpose: Intravesical instillation of Bacillus Calmette-Guerin (iBCG) is used as an effective immunotherapy of bladder cancer. However it may have, as adverse event, a reactive…
Abstract Number: 1297 • 2016 ACR/ARHP Annual Meeting
Positive Sacroiliac Joint MRI in Asymptomatic Patients with Recurrent Acute Anterior Uveitis: A Proof of Concept
Thauana Oliveira¹, Walter Maksymowych², Robert G Lambert³, Cristina Muccioli¹ and Marcelo Pinheiro¹, ¹Federal University of São Paulo, São Paulo, Brazil, ²Medicine, University of Alberta,, Edmonton, AB, Canada, ³Radiology, University of Alberta, Edmonton, AB, Canada
Background/Purpose: Recurrent acute anterior uveitis (rAAU) is associated with spondyloarthritis (SpA). However, it is not known if patients with rAAU, but no back symptoms could…
Abstract Number: 1312 • 2016 ACR/ARHP Annual Meeting
Incidence of Reactive Arthritis, Uveitis and Conjunctivitis in Japanese Patients with Bladder Cancer Following Intravesical BCG Therapy: A 20 Years’ Two-Center Retrospective Study
Satoshi Inotani^1,2,3,4, Yoshinori Taniguchi⁵, Takashi Karashima⁶, Yasuhiko Yoshinaga⁷, Hirofumi Nishikawa⁸, Natsuki Maeda⁹, Shimpei Fujimoto⁸ and Yoshio Terada¹⁰, ¹internal medicine, Chikamori Hospital, Kochi, Japan, ²Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi medical school, Nankoku, Japan, ³Urology, Kochi medical school, Nankoku, Japan, ⁴Rheumatic Disease Center, Kurashiki Medical Center, Kurashiki, Japan, ⁵Endocrinology, Metabolism,Nephrology and Rheumatology, Kochi University, Kochi, Japan, ⁶Urology, Kochi University, Nankoku, Japan, ⁷Kurashiki Medical Center, Kurashiki, Japan, ⁸Endocrinology, Metabolism, Nephrology and Rheumatology, Kochi Medical School, Nankoku, Japan, ⁹Endocrinology,Metabolism,Nephrology and Rheumatology, Kochi Medical School, Nankoku, Japan, ¹⁰Kochi University, Nankoku, Japan
Background/Purpose: To evaluate the incidence of reactive arthritis (ReA), uveitis and conjunctivitis in Japanese patients with bladder cancer following intravesical BCG therapy (iBCG). Methods: The…
Abstract Number: 2478 • 2013 ACR/ARHP Annual Meeting
Clinical Characteristics Of Patients With Early Spondyloarthritis. Results From a Specialized Consultation In a Clinical Hospital
Juan Jose Aznar Sánchez, Eugenio Chamizo Carmona, Adela Gallego Flores, Raul Veroz Gonzalez and Tamara Libertad Rodriguez Araya, Rheumatology, Hospital de Mérida, Mérida, Spain
Background/Purpose: The classification criteria for spondyloarthritis (SpA) intend to identify patients with this disease from the initial stages. The nonspecific characteristics, symptoms, signs, and additional…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].